These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16344533)

  • 21. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.
    Neves-Pereira M; Mundo E; Muglia P; King N; Macciardi F; Kennedy JL
    Am J Hum Genet; 2002 Sep; 71(3):651-5. PubMed ID: 12161822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.
    Marziniak M; Herzog AL; Mössner R; Sommer C
    J Neural Transm (Vienna); 2008 Sep; 115(9):1321-5. PubMed ID: 18478177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.
    Anttila S; Huuhka K; Huuhka M; Rontu R; Hurme M; Leinonen E; Lehtimäki T
    J Neural Transm (Vienna); 2007; 114(8):1065-8. PubMed ID: 17401528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
    Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
    J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia.
    Forero DA; Benítez B; Arboleda G; Yunis JJ; Pardo R; Arboleda H
    Neurosci Res; 2006 Jul; 55(3):334-41. PubMed ID: 16698101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder.
    Bulgin NL; Strauss JS; King NA; Shaikh SA; George CJ; Fox NA; Barr CL; Kovacs M; Kennedy JL
    Neuromolecular Med; 2008; 10(4):343-55. PubMed ID: 18543122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Lee YH; Song GG
    J Mot Behav; 2014; 46(1):59-66. PubMed ID: 24329127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis.
    Dai L; Wang D; Meng H; Zhang K; Fu L; Wu Y; Bai Y
    Int J Neurosci; 2013 Oct; 123(10):675-83. PubMed ID: 23611539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.
    Wang Q; Liu J; Guo Y; Dong G; Zou W; Chen Z
    Braz J Med Biol Res; 2019; 52(8):e8443. PubMed ID: 31365694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.